Research Output per year
Personal profile
Education/Academic qualification
Regenerative Medicine, Master of Philosophy , University of Western Australia
26 Jan 2016 → 6 May 2018
School of Public Health, Bachelor of Science, Guangdong Pharmaceutical University
1 Sep 2010 → 30 Jun 2014
Regenerative Medicine, Ph.D., University of Western Australia
2 Jul 2018 → 1 Jul 2022
External positions
Research Assistant, First Affiliated Hospital of Clinical Medicine of Guangdong Pharmaceutical University
1 Jul 2014 → 1 Oct 2015Fingerprint Dive into the research topics where Heng Qiu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Osteoclasts
Medicine & Life Sciences
Osteogenesis
Medicine & Life Sciences
Bone
Chemical Compounds
Bone Resorption
Medicine & Life Sciences
Bone and Bones
Medicine & Life Sciences
Homeostasis
Medicine & Life Sciences
Polysaccharides
Medicine & Life Sciences
Osteoporosis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2016 2019
Asperpyrone A attenuates RANKL-induced osteoclast formation through inhibiting NFATc1, Ca2+ signalling and oxidative stress
Chen, X., Wang, C., Qiu, H., Yuan, Y., Chen, K., Cao, Z., Xiang Tan, R., Tickner, J., Xu, J. & Zou, J., 1 Dec 2019, In : Journal of Cellular and Molecular Medicine. 23, 12, p. 8269-8279 11 p.Research output: Contribution to journal › Article
Open Access
Osteoclasts
Osteogenesis
Osteoporosis
Oxidative Stress
Messenger RNA
Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis
Jin, H., Wang, Q., Chen, K., Xu, K., Pan, H., Chu, F., Ye, Z., Wang, Z., Tickner, J., Qiu, H., Wang, C., Kenny, J., Xu, H., Wang, T. & Xu, J., 1 Dec 2019, In : Journal of Cellular and Molecular Medicine. 23, 12, p. 8355-8368 14 p.Research output: Contribution to journal › Article
Open Access
Osteogenesis
Bone and Bones
Osteoclasts
Osteoporosis
Bone Diseases
Chondromodulin-1 in health, osteoarthritis, cancer, and heart disease
Zhu, S., Qiu, H., Bennett, S., Kuek, V., Rosen, V., Xu, H. & Xu, J., 17 Jul 2019, In : Cellular and Molecular Life Sciences.Research output: Contribution to journal › Review article
Open Access
Osteoarthritis
Heart Diseases
Endocarditis
Health
Cartilage
Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption
Guo, Q., Cao, Z., Wu, B., Chen, F., Tickner, J., Wang, Z., Qiu, H., Wang, C., Chen, K., Tan, R., Gao, Q. & Xu, J., Jan 2019, In : Journal of Cellular Physiology. 234, 1, p. 789-801 13 p.Research output: Contribution to journal › Article
Sclareol prevents ovariectomy-induced bone loss: In vivo and inhibits osteoclastogenesis in vitro via suppressing NF-κB and MAPK/ERK signaling pathways
Jin, H., Shao, Z., Wang, Q., Miao, J., Bai, X., Liu, Q., Qiu, H., Wang, C., Zhang, Z., Jennifer, T., Wang, X. & Xu, J., 1 Oct 2019, In : Food and Function. 10, 10, p. 6556-6567 12 p.Research output: Contribution to journal › Article
ovariectomy
MAP Kinase Signaling System
osteoporosis
Ovariectomy
Osteogenesis
Prizes
AUSTRALIAN GOVERNMENT INTERNATIONAL RESEARCH TRAINING PROGRAM and University Postgraduate Award
Heng Qiu (Recipient), 2 Jul 2018
Prize: Postgraduate Scholarship